Stair Instead of Elevator Use at Work: Cardiovascular Primary Preventive Effects on Hospital Employees.

Cardiovascular Diseases Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00520195
• Other study ID #: 06-306 (med06-100)
• Status: Completed
• Phase: N/A
• First received: August 21, 2007
• Last updated: August 21, 2007
• Start date: March 2007
• Est. completion date: July 2007

Study information

• Verified date: August 2007
• Source: University Hospital, Geneva
• Contact: n/a
• Is FDA regulated: No
• Health authority: Switzerland: Ethikkommission
• Study type: Interventional

Clinical Trial Summary

This is an intervention study which evaluates the cardiovascular primary preventive effects of using stairs instead of elevators at the worksite during a 12-weeks period. We hypothesize that stair-climbing during working hours can meet the daily amount of physical activity recommended by current public health guidelines.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 77
• Est. completion date: July 2007
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age > 18 years

• No or little stair-use at work (< 5 stories/day)

• Sedentary lifestyle

Exclusion Criteria:

• Positive answers to the health screening physical activity readiness questionnaire (PAR-Q)

• Part-time employment < 80%

• Absence of more than 2 weeks during the intervention period

• Intention to begin a weight control program

• Medication changes which may influence blood pressure, lipid or glucose metabolism

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Cardiovascular Diseases

Intervention

Behavioral:
• Physical activity
Climbing stairs instead of taking elevators at worksite during 12 weeks.

Locations

Country	Name	City	State
Switzerland	University Hospitals of Geneva	Geneva

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Geneva

Country where clinical trial is conducted

Switzerland,